Comments made by lawmakers and others at the annual American Hospital
Association meeting Jan. 31 suggest legislative action on the health
care front may be more substantial than previously reported. While
election year politics usually thwart the ability of Congress to produce
meaningful legislation, Reps. Bill Thomas (R-Calif.), Charles Rangel
(D-N.Y.), and Sen. Jim Jeffords (R-Vt.) each pitched their own health
agenda which, at the very least, signal growing support for quick action
on a Medicare prescription drug benefit.
In signaling his support for a prescription drug benefit, House Ways
& Means Health Subcommittee Chair Thomas said that if there are
increased savings as a result of slower Medicare growth, the dollars
saved should be reinvested in Medicare. These savings could then be used
to fund a prescription drug benefit and other improvements to Medicare
contained in a premium support model endorsed by Rep. Thomas and the
National Bipartisan Commission on the Future of Medicare. Sen. John
Breaux (D-La.), who was Rep. Thomas' co-chairman on the commission,
recently introduced S. 1895, which seeks to replace the traditional
Medicare program with a premium support model. Rep. Thomas is expected
to introduce similar legislation in the House shortly.
Rep. Thomas also indicated that while he is open to further changes
to the 1997 Balanced Budget Act (BBA), he must see sufficient evidence
to justify additional Medicare relief before such legislation is
enacted. Cautioning that the value of any changes would be less than
last year's $17 billion, Rep. Thomas said that any new revisions would
be "a funnel, not a cylinder" and that the word refinement "means that
there should be fewer as we move forward."
Rep. Rangel appeared before the group with a loud call to enact
legislation that provides health insurance to the 44 million who
currently live without coverage. Calling for a bipartisan effort to
address the growing number of uninsured individuals across the country
Rep. Rangel said "health care has no party label" and therefore should
not fall victim to election year politics. He noted that the Health
Insurance Portability and Accountability Act and the Welfare Reform Act
were both passed in election years and that, at a very minimum, Congress
should provide some form of Medicare prescription drug benefit and
insurance coverage for parents with children who are enrolled in the
State Children's Health Insurance Program.
Picking up on the prescription drug theme, Senate Health, Education,
Labor, and Pensions Committee Chairman Jeffords said that he would do
everything in his power to pass a prescription drug benefit this year
for low-income seniors. Sen. Jeffords noted that he previously backed a
10-year $100 billion fund for that purpose and said that he is hopeful
the new Congressional Budget Office surplus estimates will improve the
prospects for enactment of a new Medicare drug benefit.
White House Chief of Staff John Podesta reiterated the
administration's support for a Medicare prescription drug benefit and
said that he hopes "this is not a prescription for deadlock."
Lawmakers in both chambers have scheduled hearings to examine the
feasibility and scope of a targeted Medicare drug benefit.
Information: Paul Bonta or Lynne L. Davis, AAMC Office of
Governmental Relations, 202-828-0526.